Document is current

Article History

Accepted: 31 January 2023

First Online: 8 March 2023

Declarations

:

: NM declares having received advisory fees from Bristol Myers Squibb and Novartis, payment for lectures and meeting invitations from Novartis, Bristol Myers Squibb, Sanofi and MSD. J-JG reports advisory/consultancy roles with Bristol Myers Squibb, MSD, Novartis, Roche, Philogen, Pierre Fabre, Sanofi, Amgen, Merck and Pfizer; and travel accommodations and/or expenses from BMS and Pierre Fabre.

: None.

: Not applicable.

: Not applicable.

: NM wrote the original draft and J-JG supervised, reviewed and edited the published work.

: Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

: Not applicable.